LEF1 reduces tumor progression and induces myodifferentiation in a subset of rhabdomyosarcoma
Open Access
- 10 December 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (2) , 3259-3273
Abstract
LEF1 reduces tumor progression and induces myodifferentiation in a subset of rhabdomyosarcoma LEF1 reduces tumor progression and induces myodifferentiation in a subset of rhabdomyosarcomaKeywords
This publication has 45 references indexed in Scilit:
- β-Catenin-Independent Activation of TCF1/LEF1 in Human Hematopoietic Tumor Cells through Interaction with ATF2 Transcription FactorsPLOS Genetics, 2013
- PI3K Inhibition Enhances Doxorubicin-Induced Apoptosis in Sarcoma CellsPLOS ONE, 2012
- Fusion Gene-Negative Alveolar Rhabdomyosarcoma is Clinically and Molecularly Indistinguishable from Embryonal RhabdomyosarcomaJournal of Clinical Oncology, 2010
- Inactivation of LEF1 in T-cell acute lymphoblastic leukemiaBlood, 2010
- The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiationJournal of Clinical Investigation, 2009
- Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975‐2005Cancer, 2009
- Molecular Classification of Rhabdomyosarcoma—Genotypic and Phenotypic Determinants of DiagnosisThe American Journal of Pathology, 2009
- A novel role for Lef-1, a central transcription mediator of Wnt signaling, in leukemogenesisJournal of Experimental Medicine, 2008
- Diversity of LEF/TCF action in development and diseaseOncogene, 2006
- Rhabdomyosarcoma – working out the pathwaysOncogene, 1999